4.6 Article

ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

Weiwei Tang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Gastroenterology & Hepatology

Goals and targets for personalized therapy for HCC

Thomas Couri et al.

HEPATOLOGY INTERNATIONAL (2019)

Review Endocrinology & Metabolism

Metformin in cancer

Ritwika Mallik et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2018)

Article Biochemistry & Molecular Biology

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Jong-Ho Cha et al.

MOLECULAR CELL (2018)

Review Biochemistry & Molecular Biology

Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells

Nipun Saini et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)

Review Oncology

Repurposing metformin for cancer treatment: current clinical studies

Young Kwang Chae et al.

ONCOTARGET (2016)

Article Clinical Neurology

Deletion of chromosome 12q21 affecting KCNC2 and ATXN7L3B in a family with neurodevelopmental delay and ataxia

Sanjeev Rajakulendran et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Article Oncology

Significance of CD90+ cancer stem cells in human liver cancer

Zhen Fan Yang et al.

CANCER CELL (2008)

Article Medicine, General & Internal

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

W. Song et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)